Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...

NHS England agreed to reimburse Vertex's newest cystic fibrosis medicine. Meanwhile, Merck advanced a once-monthly PrEP pill ...

Find earnings, economic, stock splits and IPO calendars to track upcoming financial events from Yahoo Finance.

AstraZeneca (AZN) on Monday said that its investigational drug Baxdrostat reduced systolic blood pressure (SBP) compared with ...

PORTLAND, IN, UNITED STATES, July 14, 2025 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global intelligent asthma monitoring devices market generated $180.5 ...

Discover the top 17 tech PR agencies offering PR services for technology and IT brands to boost visibility, reputation, and global reach.

The Business Research Company's Asthma and COPD Drugs Market 2025: Strategic Insights for Growth, Expansion, and Gaining Competitive Edge It will grow to $50.99 billion in 2029 at a compound annual ...

At the Paris Air Show at Le Bourget, Orbex chief executive Miguel Bello Mora announced that the company is now targeting next ...

It might be gearing up to pay billions of dollars to participate in a drug program currently in development. AstraZeneca (NASDAQ: AZN) might soon be on the hook for an eventual 11-figure payout ...

Structure verification by NMR is a vital task in drug discovery but can be slow and subjective. This article explores how ASV transforms it into a scalable, consistent and reliable process.